Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Hisashi Tsuru"'
Autor:
Eri Takada, Nobuhiko Nakamura, Yuto Kaneda, Kenji Fukuno, Shin Lee, Kei Fujita, Tetsuji Morishita, Yoshikazu Ikoma, Takuro Matsumoto, Hiroshi Nakamura, Junichi Kitagawa, Nobuhiro Kanemura, Senji Kasahara, Takeshi Hara, Hisashi Tsurumi, Masahito Shimizu
Publikováno v:
Hematology Reports, Vol 16, Iss 1, Pp 114-124 (2024)
Background: Azacitidine (AZA) is the standard treatment for patients with high-risk myelodysplastic syndromes (MDS). The impact of skeletal muscle depletion (SMD), which is associated with outcomes of hematological malignancies, on the clinical cours
Externí odkaz:
https://doaj.org/article/3f6e662b191640809793909310407127
Autor:
Nobuhiko Nakamura, Nobuhiro Kanemura, Takuro Matsumoto, Hiroshi Nakamura, Yoshikazu Ikoma, Yuhei Shibata, Junnichi Kitagawa, Senji Kasahara, Toshiki Yamada, Michio Sawada, Yuto Kaneda, Kenji Fukuno, Eri Takada, Hideko Goto, Shin Lee, Kei Fujita, Tetsuji Morishita, Takeshi Hara, Hisashi Tsurumi, Masahito Shimizu
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract We compared the predictive ability of the International Prognostic Index (IPI), a frequently used prognostic model for peripheral T-cell lymphoma (PTCL), with that of a type-specific prognostic model, the Prognostic Index for PTCL-U (PIT). W
Externí odkaz:
https://doaj.org/article/5ee866dc54af4b92bbcb8e8dae41d734
Autor:
Masashi Ishihara, Shinichi Hikasa, Mariko Tsukiji, Yusuke Kunimoto, Kazuko Nobori, Takeshi Kimura, Kenta Onishi, Yuki Yamamoto, Kyohei Haruta, Yohei Kashiwabara, Kenji Fujii, Shota Shimabukuro, Daichi Watanabe, Hisashi Tsurumi, Akio Suzuki
Publikováno v:
AIDS Research and Therapy, Vol 20, Iss 1, Pp 1-9 (2023)
Abstract Background Long-acting injectable formulations for HIV infection have been approved and are now available in Japan. Although not currently recommended as first-line drugs in Japanese or overseas guidelines, use of such formulations may incre
Externí odkaz:
https://doaj.org/article/7ee102a1dcdf4f4eab4ee02feb91b21a
Autor:
Yasuko Yamamoto, Hisashi Tsurumi, Masao Takemura, Kuniaki Saito, Makoto Hayashi, Tetsuji Morishita, Hidetoshi Matsunami
Publikováno v:
BMJ Open, Vol 14, Iss 2 (2024)
Purpose The increased global burden of non-communicable diseases and mental disorders is an urgent health challenge for countries around the entire world, especially those experiencing super-ageing societies, where over 21% of the population is age 6
Externí odkaz:
https://doaj.org/article/5f723b82940043e09c81648069db157e
Autor:
Kazunori Arita, Toshiyuki Yamamoto, Nayuta Higa, Keiko Shimojima, Nozomi Sano, Tatsuki Oyoshi, Hisashi Tsuru, Hiroshi Tokimura, Mayumi Matsufuji, Yumiko Ondo
Publikováno v:
European Journal of Medical Genetics. 59:559-563
A female patient presented with developmental delay, distinctive facial features, and congenital anomalies, including a heart defect and premature lambdoid synostosis. The patient showed a paternally inherited 16p13.11 microduplication and a de novo
Autor:
Shin Lee, Yusuke Kito, Kei Fujita, Hiroto Wakayama, Masaki Kimura, Keisuke Kawashima, Tetsuya Tabata, Tadashi Yoshino, Takeshi Hara, Hisashi Tsurumi
Publikováno v:
eJHaem, Vol 3, Iss 4, Pp 1335-1338 (2022)
Abstract We describe a case of unclassifiable T/NK‐cell lymphoma with concomitant acute myeloid leukemia (AML). A 73‐year‐old Japanese man was diagnosed with AML by bone marrow smear, but the presence of splenomegaly and liver tumor was incompa
Externí odkaz:
https://doaj.org/article/118272c9a5ab4160ade3b01a447c96a6
Publikováno v:
Braindevelopment. 39(9)
Objective To determine the morphological characteristics and pathogenic factors of cerebellar injury in extremely low birth weight infants (ELBWI). Subjects and methods Neuroimaging examination was performed on 17 eligible surviving ELBWI. Their MR i
Autor:
Nobuhiko Nakamura, Senji Kasahara, Junichi Kitagawa, Hiroshi Nakamura, Michio Sawada, Kenji Fukuno, Yuhei Shibata, Yuto Kaneda, Takeshi Hara, Nobuhiro Kanemura, Hisashi Tsurumi, Masahito Shimizu
Publikováno v:
Experimental Hematology & Oncology, Vol 11, Iss 1, Pp 1-4 (2022)
Abstract This phase II clinical trial aimed to evaluate the efficacy and safety of the combination therapy of bendamustine, cytarabine, and rituximab (BRAC) in patients with relapsed or refractory follicular lymphoma (FL) or mantle cell lymphoma (MCL
Externí odkaz:
https://doaj.org/article/4a50d6ba4f5c4b779cf8a8a8f13c391a
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 1066-1067 (2022)
Externí odkaz:
https://doaj.org/article/71f604874a384261bdedaf0ac5c20ac4
Autor:
Kuniaki Yabe, Yasuko Yamamoto, Masao Takemura, Takeshi Hara, Hisashi Tsurumi, Ginette Serrero, Toshitaka Nabeshima, Kuniaki Saito
Publikováno v:
Heliyon, Vol 7, Iss 1, Pp e05849- (2021)
Progranulin is an autocrine growth factor that promotes proliferation, migration, invasion, and chemoresistance of various cancer cells. These mechanisms mainly depend on the protein kinase B (Akt)/mechanistic target of rapamycin (mTOR) pathway. Rece
Externí odkaz:
https://doaj.org/article/921a27ff7400478588891f966ed80494